A Virtual Event

This virtual conference is designed for physicians, nurses, nurse practitioners, pharmacists, physician assistants, child life specialists and social workers practicing in the field of pediatric and adult oncology or primary care. It will provide a learning opportunity to the health care community to expand their knowledge about treating their patients and bring to surface the real topics of discussion of today’s modern challenges. The day will end with a provocative patient driven discussion which will include a well-rounded parent panel and faculty interaction.

Complete conference details and registration information coming soon.

The Roosevelt Hotel
New Orleans, LA

The 17TH Annual New Orleans Summer Cancer Meeting (NOSCM) is the largest continuing medical education (CME) event in the US Southeast region. It is a 3-day national CME, nursing education (CE), pharmacist and physician assistant meeting designed for medical oncologists, hematologists, surgical oncologists, radiation oncologists, oncology nurses, nurse practitioners, pharmacists, physician assistants, residents, and fellows in Hematology/Oncology as well as other healthcare professionals involved in the management of cancer patients.

The 17th Annual NOSCM will have a long list of experts in the field of malignant diseases; guest faculty will discuss important topics in the management of cancer patients not only novel therapies such as immunotherapy, targeted agents, and cytotoxic agents but also the management of side effects, survivorship, palliative care, liquid biopsy, and biosimilars in oncology. The meeting will have deep discussions on immunotherapy for different tumor types. Immunotherapy has improved the overall survival of many tumor types; how to improve these outcomes and how to deal with immunotherapy resistance will be discussed during this educational activity.

For complete conference details, hotel and registration information please visit NOSCM.com

The Langham Pasadena Hotel

Pasadena, California

This conference will bring together top oncologists for a comprehensive review and updated data in hematology, medical oncology, gynecology malignancies, immunotherapy, supportive care, healthcare policies and novel technologies in cancer management. This conference aims to provide up-to-date information to the clinician regarding new advances in cancer biology, diagnosis, and treatment. It will bring together respected opinion leaders, practicing clinicians and scientists engaged in clinical cancer research to discuss the latest cancer diagnostic and therapeutic advances.

For complete conference details, hotel and registration information please visit CCC 2022

Loews Vanderbilt Hotel

Nashville, Tennessee

This master lecture series will provide the most up-to-date, practical information on the management of breast cancer, lung cancer, gastrointestinal, genitourinary and melanoma in 2021. Immunotherapy and target therapies will be discussed in personalized treatments, and the latest clinical data impacting the management of these cancers. We will discuss the most current data in GI, GU (PARP Inhibitors), Melanoma (Immunotherapy/BRAF), Lung (RET/MET/VEGFR2) and breast cancer (HER2 P13K/Akt/TROP2).

Cutting edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses and management plan options for their patients.

For complete conference details, hotel and registration information please visit MLS Nashville

Denver, Colorado

This master lecture series will provide the most up-to-date, practical information on the management of breast cancer, lung cancer, gastrointestinal, genitourinary and melanoma in 2021. Immunotherapy and target therapies will be discussed in personalized treatments, and the latest clinical data impacting the management of these cancers. We will discuss the most current data in GI, GU (PARP Inhibitors), Melanoma (Immunotherapy/BRAF), Lung (RET/MET/VEGFR2) and breast cancer (HER2 P13K/Akt/TROP2).

Cutting-edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses and management plan options for their patients.

For complete conference details, hotel and registration information please visit MLS Denver

Westin New Orleans

New Orleans, LA

This master lecture series will provide the most up-to-date, practical information on the management of breast cancer, lung cancer, gastrointestinal, genitourinary, and melanoma in 2021. Immunotherapy and target therapies will be discussed in personalized treatments, and the latest clinical data impacting the management of these cancers. We will discuss the most current data in GI, GU (PARP Inhibitors), Melanoma (Immunotherapy/BRAF), Lung (RET/MET/VEGFR2), and breast cancer (HER2 P13K/Akt/TROP2).

Cutting-edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses, and management plan options for their patients.

For complete conference details, hotel and registration information please visit MLS New Orleans

Miami, Florida

Updates in Cancer Therapies: An ASCO/ESMO Review has been developed as a CME/CE activity focusing on the highlights of recent developments presented at this year’s two important international congresses delivering a clear and high-quality comprehensive educational program with key opinion leaders in each cancer field. This two-day live in person event will consist of presentations and questions & answer sessions on key topics in cancer care.

For complete conference details, hotel and registration information please visit Updates in Cancer Therapies website

Kimpton Sawyer Hotel

Sacramento, California

As a result of prior course participant evaluations and needs assessment surveys, the need for cutting-edge information on prognostic markers and the appropriate application of novel therapies has been identified. This year’s conference will specifically address these needs in the common malignancies identified by past participants as essential to their practice, including solid and hematologic cancers. The timing of this meeting in the fall allows for the latest findings in clinical cancer research from major hematology and oncology conferences to be presented and discussed. This educational activity also meets a unique need for the Northern California Sacramento Valley to provide a group of networked and collaborating oncologists a forum to discuss the most recent developments in oncology care in the context of local treatment approaches, patient populations, and open clinical trials.

Complete conference information coming soon.

Best of WCLC 2022 San Francisco

San Francisco, CA

The Best of WCLC is an educational initiative of the IASLC designed to present a multidisciplinary and multi-specialty approach to education, engaging both community and academic practitioners unable to attend the World Conference on Lung Cancer. The “Best of” program will condense the most exciting and practice-changing data from multiple disciplines into a single-day event (see agenda) to optimize information transfer from the WCLC to busy health

care professionals, with a focus on the most important advances in the care of patients with thoracic malignancies. The program is designed to increase attendee competency in the latest developments in the field, translating into improved practice patterns.

Complete conference information coming soon.

San Francisco, CA

The lecture series will provide current, practical information on the management of immunotherapy and target therapies. We will discuss the novel agents and strategies with the potential to shape the future of cancer therapy. Leading experts will address critical topics in personalized therapy, and the latest clinical data impacting the treatment of GI, GU (PAR Inhibitors), melanoma, lung (RET/MET/ VEGFR2 & breast cancer (HER2 PI3K/Akt). The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses, and management plan options for their patients. This educational activity has been designed to meet the educational needs of medical oncologists, and health care professionals involved in the treatment of cancer.

Complete conference information coming soon.